Skip to main content
FinSpry Logo
FinSpry
DMAC logo
DMAC
(NASDAQ)
DiaMedica Therapeutics Inc.
$6.48-- (--)
Loading... - Market loading
OverviewFinancialsForecastStatisticsDividendsHistoricalProfile

DiaMedica Therapeutics (DMAC) Stock Price & Financial Analysis

DiaMedica Therapeutics Stock Price Chart

Price Chart

Loading chart...

Financial Metrics & Key Statistics

Fundamental metrics, valuation ratios, and profitability indicators

Day's Range$6.20 - $6.51
52-Week High$10.42
52-Week Low$3.19
Open$6.40
Volume131.42K
Average Volume (3M)131.42K
Market Cap321.60M
Shares Outstanding49.63M
Price to Book (P/B)6.17
EV/EBITDA-9.40
50-Day MA$7.82
200-Day MA$6.76
52-Week Change71.20%
Annual Dividend$0.00
Dividend Yield0.00%

Frequently Asked Questions About DiaMedica Therapeutics

What is the current stock price for DMAC?

As of the latest trading session, DMAC stock trades at $6.48. The 52-week range is $3.19–$10.42, with a day range of $6.20–$6.51.

What is the P/E ratio for DMAC?

The P/E ratio (Price-to-Earnings) for DMAC is shown in the Key Statistics section. This valuation metric helps compare DiaMedica Therapeutics Inc. to industry peers.

Does DMAC pay dividends?

DiaMedica Therapeutics does not currently pay a regular dividend. The company reinvests earnings into growth and operations. Check the Dividends tab for historical dividend information.

What do analysts recommend for DMAC?

Analyst ratings and recommendations for DMAC are displayed in the Analyst Consensus section, including buy/hold/sell distribution and 12-month price targets.

What is the market cap of DMAC?

DiaMedica Therapeutics's market capitalization is $321.6M, classifying it as a small-cap company. DiaMedica Therapeutics operates in the Healthcare sector within the Biotechnology industry.